Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Risk factors of tumor lysis syndrome in childhood acute lymphoblastic leukemia

Universa Medicina · Vol. 43 No. 3 (2024) · hlm. 265–271

DOI
10.18051/UnivMed.2024.v43.265-271
ISSN
2407-2230, 1907-3062
Terbit
2024-10-08
Penerbit
Faculty of Medicine, Universitas Trisakti
Bahasa
eng
Lisensi
creativecommons.org/licenses/by-nc-sa/4.0

Abstrak

BackgroundAcute lymphoblastic leukemia (ALL) is the most common childhood hematologic malignancy. Treatment failure in ALL can be caused by severe and life-threatening complications, including tumor lysis syndrome (TLS). Delay in identifying risk factors and establishing the diagnosis of TLS by clinicians can be fatal. This study aimed to determine the risk factors for TLS in children with ALL. MethodsThis was a retrospective cross-sectional study on 81 children aged 0 to 18 years with ALL. Tumor lysis syndrome comes in two forms: laboratory and clinical. Laboratory TLS occurs if uric acid levels >normal values, potassium >6mEq/L, phosphate >6.5mg/dl, and calcium <7mg/dl. Clinical TLS includes an increase in serum creatinine, the presence of heart attacks, sudden death, and seizures. Risk factors for TLS include age, nutritional status, leukocyte count, presence of organ infiltration, presence of mediastinal mass, uric acid level, renal function, and type of chemotherapy regimen. Risk factors were analyzed using simple and multiple logistic regression analyses. A value of p<0.05 indicates a significant risk factor. ResultsTwenty seven patients (33.3%) experienced TLS. Adjusted OR analysis showed that the presence of organ infiltration (aOR 5.42; 95% CI 1.45-20.27; p=0.012), leukocyte count (aOR 8.70; 95% CI 1.67-45.13; p=0.010), and decreased kidney function (aOR 12.21; 95% CI 1.09-136.89; p=0.042) were significant risk factors for TLS. ConclusionDecreased renal function, leukocyte count, and organ infiltration were significant risk factors for TLS. We suggest more vigilant assessment and monitoring to recognize and treat those patients who are at risk of TLS.

Kata kunci

Jaringan kolaborasi para penulis

16 penulis · 34 tautan kepenulisan bersama · 3 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universitas Airlangga
  • Rumah Sakit Dokter Soetomo
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
I Dewa Gede UgrasenaUniversitas Airlangga2
Mariyatul QibtiyahRumah Sakit Dokter Soetomo1
Yulistiani YulistianiUniversitas Airlangga1
Levana RismayantiUniversitas Airlangga1
Sjamsul AriefUniversitas Airlangga1
Dwi Putri Ari SAfiliasi tidak diketahui1
Regina Rania Cahya Kusumaningrum -Universitas Airlangga1
Puspa WardhaniUniversitas Airlangga1
Nurul MuhlisaAfiliasi tidak diketahui1
Yetti HernaningsihAfiliasi tidak diketahui1
Zulfikar Ali HasanAfiliasi tidak diketahui1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://univmed.org/ejurnal/index.php/medicina/oai, pertama di-harvest 10 Nov 2026, terakhir terlihat 16 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Risk factors of tumor lysis syndrome in childhood acute lymphoblastic leukemia</dc:title>
	<dc:creator xml:lang="en">Andarsini, Mia Ratwita</dc:creator>
	<dc:creator xml:lang="en">Hartono, Audylia</dc:creator>
	<dc:creator xml:lang="en">Cahyadi, Andi</dc:creator>
	<dc:creator xml:lang="en">Larasati, Maria Christina Shanty</dc:creator>
	<dc:creator xml:lang="en">Asmara, Almeir Pradhipta Andras </dc:creator>
	<dc:subject xml:lang="en">Acute lymphoblastic leukemia</dc:subject>
	<dc:subject xml:lang="en">tumor lysis syndrome</dc:subject>
	<dc:subject xml:lang="en">risk factor</dc:subject>
	<dc:subject xml:lang="en">renal function</dc:subject>
	<dc:subject xml:lang="en">children</dc:subject>
	<dc:description xml:lang="en">BackgroundAcute lymphoblastic leukemia (ALL) is the most common childhood hematologic malignancy. Treatment failure in ALL can be caused by severe and life-threatening complications, including tumor lysis syndrome (TLS). Delay in identifying risk factors and establishing the diagnosis of TLS by clinicians can be fatal. This study aimed to determine the risk factors for TLS in children with ALL.
MethodsThis was a retrospective cross-sectional study on 81 children aged 0 to 18 years with ALL. Tumor lysis syndrome comes in two forms: laboratory and clinical. Laboratory TLS occurs if uric acid levels &amp;gt;normal values, potassium &amp;gt;6mEq/L, phosphate &amp;gt;6.5mg/dl, and calcium &amp;lt;7mg/dl. Clinical TLS includes an increase in serum creatinine, the presence of heart attacks, sudden death, and seizures. Risk factors for TLS include age, nutritional status, leukocyte count, presence of organ infiltration, presence of mediastinal mass, uric acid level, renal function, and type of chemotherapy regimen. Risk factors were analyzed using simple and multiple logistic regression analyses. A value of p&amp;lt;0.05 indicates a significant risk factor.
ResultsTwenty seven patients (33.3%) experienced TLS. Adjusted OR analysis showed that the presence of organ infiltration (aOR 5.42; 95% CI 1.45-20.27; p=0.012), leukocyte count (aOR 8.70; 95% CI 1.67-45.13; p=0.010), and decreased kidney function (aOR 12.21; 95% CI 1.09-136.89; p=0.042) were significant risk factors for TLS.
ConclusionDecreased renal function, leukocyte count, and organ infiltration were significant risk factors for TLS. We suggest more vigilant assessment and monitoring to recognize and treat those patients who are at risk of TLS.</dc:description>
	<dc:publisher xml:lang="en">Faculty of Medicine, Universitas Trisakti</dc:publisher>
	<dc:date>2024-10-08</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://univmed.org/ejurnal/index.php/medicina/article/view/1599</dc:identifier>
	<dc:identifier>10.18051/UnivMed.2024.v43.265-271</dc:identifier>
	<dc:source xml:lang="en">Universa Medicina; Vol. 43 No. 3 (2024); 265-271</dc:source>
	<dc:source>2407-2230</dc:source>
	<dc:source>1907-3062</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://univmed.org/ejurnal/index.php/medicina/article/view/1599/794</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2024 Mia Ratwita Andarsini, Audylia Hartono, Andi Cahyadi, Maria Christina Shanty Larasati, Almeir Pradhipta Andras  Asmara</dc:rights>
	<dc:rights xml:lang="en">https://creativecommons.org/licenses/by-nc-sa/4.0</dc:rights>
</oai_dc:dc>